Biomarkers for Oncology
JH · Effective Oct 1, 2015
42 active Medicare policies list D01.5, and 7 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J9 · Effective Oct 1, 2015
7 policies from 2 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of D01.5 |
|---|---|---|
| Ablation of Hepatic Lesions | Nov 9, 2023 | Covered |
| Magnetic Resonance Cholangiopancreatography | Feb 15, 2024 | Covered |
| Pancreaticoduodenectomy (Whipple Resection) | Jun 5, 2023 | Covered |
| Tumor Markers | Mar 5, 2024 | Covered |
| Policy | Effective | Status of D01.5 |
|---|---|---|
| Carcinoembryonic Antigen Testing | Oct 1, 2026 |
J6
J6 · Effective Jul 15, 2026
JK · Effective Jul 15, 2026
JJ · Effective Jul 24, 2022
JM · Effective Jul 24, 2022
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J15 · Effective Aug 21, 2022
JE · Effective Aug 8, 2022
JF · Effective Aug 8, 2022
JJ · Effective Jul 3, 2022
JM · Effective Jul 3, 2022
J5 · Effective Jul 3, 2022
J8 · Effective Jul 3, 2022
J9 · Effective Oct 1, 2015
JJ · Effective Jun 12, 2017
JM · Effective Jun 12, 2017
JL · Effective Apr 24, 2025
National · Effective Oct 1, 2025
National · Effective Oct 1, 2026
National · Effective Oct 1, 2026
J9 · Effective Oct 1, 2025
National · Effective Oct 1, 2026
National · Effective Jul 15, 2026
National · Effective Oct 1, 2026
National · Effective Aug 6, 2026
National · Effective Aug 13, 2026
National · Effective Aug 6, 2026
J5 · Effective Aug 6, 2026
National · Effective Oct 30, 2025
National · Effective Jul 1, 2026
National · Effective Oct 1, 2026
| Covered |
| Cryosurgical, Radiofrequency, Microwave, or Percutaneous Ethanol Ablation to Treat Solid Tumors in the Liver | Apr 15, 2026 | Covered |
|---|
| Outpatient Alpha-Fetoprotein Testing | Apr 15, 2026 | Covered |
|---|